3-Methylbut-2-enoyl chloride

We are 3-Methylbut-2-enoyl chloride CAS:3350-78-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-Methylbut-2-enoyl chloride
CAS.NO:3350-78-5
Synonyms:3-Methylbut-2-enoyl chloride
3-methylcrotonoyl chloride
3-methyl-but-2-en-1-oyl chloride
3,3-dimethylacrylic acid chloride
3-Methyl-2-butenoyl chloride
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 146.0±0.0 °C at 760 mmHg
Molecular Formula C5H7ClO
Molecular Weight 118.562
Flash Point 51.1±0.0 °C
Vapour Pressure 4.7±0.2 mmHg at 25°C
Index of Refraction 1.444
 
Specification:
Appearance:Colourless to light yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ciclopirox(CAS:29342-05-0).

3-Methylbut-2-enoyl chloride


Related News: The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.328-84-7 In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.2-Azabiciclo [3.1.0] hexano-3-carbonitrilo, (1S, 3S, 5S) – CAS:866083-42-3 Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.octamethylcyclotetrasiloxane CAS:556-67-2 Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.“With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”

Related Products
Product Name
ammonium O,O-diisopropyl phosphorothioate View Details
Ethyl 2-(triphenylphosphoranylidene)propionate View Details
Thymidine 5′-Triphosphate Sodium Salt View Details
4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile,hydrochloride manufacturer N-Methyl-N-Cbz-D-alanine manufacturer 4-Hydroxypyridine manufacturer Z-N-Methyl-D-valine manufacturer 2-Bromo-5-chlorophenol manufacturer